{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:33Z","timestamp":1740185013087,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Nierenbiopsiediagnostik bei medizinisch indizierten Biopsien und Nierentransplantatbiopsien wird \u00fcberwiegend in Zentren mit ausgebildeten Nephropathologen betrieben. Ver\u00e4nderungen im nichtneoplastischen Nierenparenchym bei tumorbedingten Nephrektomien, insbesondere nichtentz\u00fcndliche, isch\u00e4misch und vaskul\u00e4r bedingte Ver\u00e4nderungen oder diabetische Nephropathie, k\u00f6nnen bei Patienten mit lokalisiertem Nierenkarzinomen und gutem tumorassoziiertem \u00dcberleben prognostisch von gr\u00f6\u00dferer Bedeutung sein als das Tumorleiden an sich. In diesem Teil zu den Grundlagen der Nierenpathologie f\u00fcr Pathologen sollen die h\u00e4ufigsten nichtentz\u00fcndlichen Nierenerkrankungen im vaskul\u00e4ren, glomerul\u00e4ren und tubulointerstitiellen Kompartiment beleuchtet werden.<\/jats:p>","DOI":"10.1007\/s00292-023-01204-6","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T10:02:57Z","timestamp":1687860177000},"page":"261-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Grundlagen der Nierenpathologie f\u00fcr Pathologen\u00a0\u2013 Teil\u00a02","Basic nephropathology for pathologists\u2014part\u00a02"],"prefix":"10.1007","volume":"44","author":[{"given":"Ariana","family":"Gaspert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"B\u00fcttner-Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semnephrol.2019.12.008","volume":"40","author":"KJ Henriksen","year":"2020","unstructured":"Henriksen\u00a0KJ, Chang\u00a0A (2020) The importance of nephropathology in kidney cancer. Semin Nephrol 40:69\u201375","journal-title":"Semin Nephrol"},{"key":"1204_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.pas.0000194296.74097.87","volume":"30","author":"V Bijol","year":"2006","unstructured":"Bijol\u00a0V, Mendez\u00a0GP, Hurwitz\u00a0S et\u00a0al (2006) Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: Predicting the risk of progressive renal failure. Am J Surg Pathol 30:575\u2013584","journal-title":"Am J Surg Pathol"},{"key":"1204_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/PAS.0b013e31804ca63e","volume":"31","author":"KJ Henriksen","year":"2007","unstructured":"Henriksen\u00a0KJ, Meehan\u00a0SM, Chang\u00a0A (2007) Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens. Am J Surg Pathol 31:1703\u20131708","journal-title":"Am J Surg Pathol"},{"key":"1204_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.5858\/133.7.1012","volume":"133","author":"KJ Henriksen","year":"2009","unstructured":"Henriksen\u00a0KJ, Meehan\u00a0SM, Chang\u00a0A (2009) Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens. Arch Pathol Lab Med 133:1012\u20131025","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1681\/ASN.2017040421","volume":"28","author":"MS Hommos","year":"2017","unstructured":"Hommos\u00a0MS, Glassock\u00a0RJ, Rule\u00a0AD (2017) Structural and functional changes in human kidneys with healthy aging. J\u00a0Am Soc Nephrol 28(10):2838\u20132844","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/ndt\/gfv072","volume":"30","author":"WK Kremers","year":"2015","unstructured":"Kremers\u00a0WK, Denic\u00a0A, Lieske\u00a0JC et al (2015) Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 30(12):2034\u20132039","journal-title":"Nephrol Dial Transplant"},{"key":"1204_CR7","volume-title":"Protocol for the examination of resection specimens from patients with invasive carcinoma of renal tubular origin. Version 4.1.0.0","author":"JR Srigley","year":"2021","unstructured":"Srigley\u00a0JR, Paner\u00a0GP, Zhou\u00a0M et\u00a0al (2021) Protocol for the examination of resection specimens from patients with invasive carcinoma of renal tubular origin. College of American Pathologists"},{"key":"1204_CR8","volume-title":"Diagnostic pathology. Kidney diseases","author":"RB Colvin","year":"2019","unstructured":"Colvin\u00a0RB, Chang\u00a0A (2019) Diagnostic pathology. Kidney diseases. Elsevier"},{"key":"1204_CR9","volume-title":"Diagnostic Atlas of renal pathology","author":"AB Fogo","year":"2017","unstructured":"Fogo\u00a0AB, Kashgarian\u00a0M (2017) Diagnostic Atlas of renal pathology. Elsevier"},{"key":"1204_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2215\/CJN.00620117","volume":"13","author":"V Brocklebank","year":"2018","unstructured":"Brocklebank\u00a0V, Wood\u00a0KM, Kavanagh\u00a0D (2018) Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol 13:300\u2013317","journal-title":"Clin J Am Soc Nephrol"},{"key":"1204_CR11","doi-asserted-by":"publisher","first-page":"1088031","DOI":"10.3389\/fphar.2022.1088031","volume":"13","author":"T Mazzierli","year":"2023","unstructured":"Mazzierli\u00a0T, Allegretta\u00a0F, Maffini\u00a0E, Allinovi\u00a0M (2023) Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management. Front Pharmacol 13:1088031. https:\/\/doi.org\/10.3389\/fphar.2022.1088031","journal-title":"Front Pharmacol"},{"issue":"6","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/his.13716","volume":"73","author":"F Pfister","year":"2018","unstructured":"Pfister\u00a0F, Amann\u00a0K, Daniel\u00a0C et al (2018) Characteristic morphological changes in anti.VEGF therapy-induced glomerular microangiopathy. Histopathology 73(6):990\u20131001","journal-title":"Histopathology"},{"key":"1204_CR13","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S0140-6736(09)62073-0","volume":"375","author":"F Scolari","year":"2010","unstructured":"Scolari\u00a0F, Ravani\u00a0P (2010) Atheroembolic renal disease. Lancet 375:1650\u20131660","journal-title":"Lancet"},{"key":"1204_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette\u00a0JC, Falk\u00a0RJ, Bacon\u00a0PA et\u00a0al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"1204_CR15","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","volume":"102","author":"C Roufosse","year":"2018","unstructured":"Roufosse\u00a0C, Simmonds\u00a0N, Clahsen-Van Groningen\u00a0M et al (2018) A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation 102:1795\u20131814","journal-title":"Transplantation"},{"key":"1204_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert\u00a0TW, Mooyaart\u00a0AL, Amann\u00a0K et\u00a0al (2010) Pathologic classification of diabetic nephropathy. J\u00a0Am Soc Nephrol 21:556\u2013563","journal-title":"J Am Soc Nephrol"},{"key":"1204_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000371727","volume":"41","author":"SP Salvatore","year":"2015","unstructured":"Salvatore\u00a0SP, Troxell\u00a0ML, Hecox\u00a0D et al (2015) Smoking-related glomerulopathy: Expanding the morphologic spectrum. Am J Nephrol 41:66\u201372","journal-title":"Am J Nephrol"},{"key":"1204_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5858\/arpa.2012-0070-OA","volume":"137","author":"SP Salvatore","year":"2013","unstructured":"Salvatore\u00a0SP, Cha\u00a0EK, Rosoff\u00a0JS et\u00a0al (2013) Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Arch Pathol Lab Med 137:531\u2013540","journal-title":"Arch Pathol Lab Med"},{"key":"1204_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","volume":"27","author":"MD Benson","year":"2020","unstructured":"Benson\u00a0MD, Buxbaum\u00a0JN, Eisenberg\u00a0DS et\u00a0al (2020) Amyloid nomenclature 2020: Update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid 27:217\u2013222","journal-title":"Amyloid"},{"key":"1204_CR20","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3332\/ecancer.2020.1156","volume":"14","author":"MA Algarra","year":"2020","unstructured":"Algarra\u00a0MA, Fita\u00a0MJJ, Sandiego\u00a0S et\u00a0al (2020) Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma. ecancer 14:1156","journal-title":"ecancer"},{"key":"1204_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s13730-022-00728-9","volume":"12","author":"AJ Gallan","year":"2023","unstructured":"Gallan AJ, Bhasin-Chhabra B, Kilari D et al (2023) Bystander LECT1 amyloidosis in tumor nephrectomy. CEN Case Rep. 12:104\u2013109","journal-title":"CEN Case Rep"},{"issue":"2","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"A Fogo","year":"2015","unstructured":"Fogo\u00a0A (2015) Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11(2):76\u201387","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg\u00a0AZ, Kopp\u00a0JB (2017) Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 12(3):502\u2013517","journal-title":"Clin J Am Soc Nephrol"},{"key":"1204_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00345-011-0720-1","volume":"31","author":"M Garcia-Roig","year":"2013","unstructured":"Garcia-Roig\u00a0M, Gorin\u00a0MA, Parra-Herran\u00a0C et al (2013) Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens. World J Urol 31:835\u2013839","journal-title":"World J Urol"},{"issue":"3","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.ackd.2021.08.003","volume":"29","author":"CE Kashtan","year":"2022","unstructured":"Kashtan\u00a0CE (2022) What the adult nephrologist should know about Alport syndrome. Adv Chronic Kidney Dis 29(3):225\u2013230","journal-title":"Adv Chronic Kidney Dis"},{"key":"1204_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan\u00a0CE, Ding\u00a0J, Garosi\u00a0G et\u00a0al (2018) Alport syndrome: A unified classification of genetic disorders of collagen IV \u03b1345: A position paper of the Alport syndrome classification working group. Kidney Int 93:1045\u20131051","journal-title":"Kidney Int"},{"key":"1204_CR27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1053\/ajkd.2003.50143","volume":"41","author":"SH Nasr","year":"2003","unstructured":"Nasr\u00a0SH, Koscica\u00a0J, Markowitz\u00a0GS et\u00a0al (2003) Granulomatous interstitial nephritis. Am J Kidney Dis 41:714\u2013719","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1204_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/106689690601400110","volume":"14","author":"V Bijol","year":"2006","unstructured":"Bijol\u00a0V, Mendez\u00a0GP, Nos\u00e9\u00a0V et\u00a0al (2006) Granulomatous interstitial nephritis: A clinicopathologic study of 46\u00a0cases from a\u00a0single institution. Int J Surg Pathol 14(1):57\u201363","journal-title":"Int J Surg Pathol"},{"key":"1204_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/ckj\/sfv053","volume":"8","author":"S Shah","year":"2015","unstructured":"Shah\u00a0S, Carter-Monroe\u00a0N, Atta\u00a0MG (2015) Granulomatous interstitial nephritis. Clin Kidney\u00a0J 8:516\u2013523","journal-title":"Clin Kidney J"},{"key":"1204_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","volume":"351","author":"GS Markowitz","year":"2005","unstructured":"Markowitz\u00a0GS, Perazella\u00a0MA (2005) Drug-induced renal failure: a\u00a0focus on tubulointerstitial disease. Clin Chim Acta 351:31\u201347","journal-title":"Clin Chim Acta"},{"key":"1204_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","volume":"90","author":"FB Cortazar","year":"2016","unstructured":"Cortazar\u00a0FB, Marrone\u00a0KA, Troxell\u00a0ML et\u00a0al (2016) Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int 90:638\u2013647","journal-title":"Kidney Int"},{"issue":"7","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/diagnostics11071187","volume":"11","author":"J Belliere","year":"2021","unstructured":"Belliere\u00a0J, Mazieres\u00a0J, Meyer at\u00a0N et\u00a0al (2021) Renal complications related to checkpoint inhibitors: Diagnostic and therapeutic strategies. Diagnostics 11(7):1187","journal-title":"Diagnostics"},{"key":"1204_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMc0904283","volume":"361","author":"F Fadel","year":"2009","unstructured":"Fadel\u00a0F, Karoui\u00a0K, Knebelmann\u00a0B (2009) Anti-CTLA4 antibody-induced lupus nephritis. N\u00a0Engl J Med 361:211\u2013212","journal-title":"N Engl J Med"},{"issue":"6","key":"1204_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.ajkd.2019.04.016","volume":"74","author":"AJ Gallan","year":"2019","unstructured":"Gallan\u00a0AJ, Alexander\u00a0E, Reid\u00a0P et al (2019) Renal vasculitis and pauci-immune glomerulonephritis associated with immune checkpoint inhibitors. Am J Kidney Dis 74(6):853\u2013856","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1204_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1053\/j.ajkd.2013.11.028","volume":"63","author":"S Akilesh","year":"2014","unstructured":"Akilesh\u00a0S, Juaire\u00a0N, Duffield\u00a0JS, Smith\u00a0KD (2014) Chronic ifosfamide toxicity: Kidney pathology and pathophysiology. Am J Kidney Dis 63(5):843\u2013850","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1204_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MNH.0000000000000201","volume":"25","author":"S Sethi","year":"2016","unstructured":"Sethi\u00a0S, Rajkumar\u00a0SV, D\u2019Agati\u00a0VD (2016) Spectrum of manifestations of monoclonal gammopathy-associated renal lesions. Curr Opin Nephrol Hypertens 25(2):127\u2013137","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1204_CR37","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1681\/ASN.2017121319","volume":"29","author":"S Sethi","year":"2018","unstructured":"Sethi\u00a0S, Rajkumar\u00a0SV, D\u2019agati\u00a0VD (2018) The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J\u00a0Am Soc Nephrol 29:1810\u20131823","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1204_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.semdp.2020.02.001","volume":"37","author":"Z Dvanajscak","year":"2020","unstructured":"Dvanajscak\u00a0Z, Cossey\u00a0LN, Larsen\u00a0CP et\u00a0al (2020) A practical approach to the pathology of renal intratubular casts. Semin Diagn Pathol 37(3):127\u2013134","journal-title":"Semin Diagn Pathol"},{"issue":"7","key":"1204_CR39","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.ekir.2021.04.035","volume":"6","author":"N Tantranont","year":"2021","unstructured":"Tantranont\u00a0N, Luque\u00a0Y, Hsiao\u00a0M et al (2021) Vancomycin-associated tubular casts and vancomycin nephrotoxicity. Kidney Int Rep 6(7):1912\u20131922","journal-title":"Kidney Int Rep"},{"issue":"4","key":"1204_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/01.ASN.0000057542.86377.5A","volume":"14","author":"KD Smith","year":"2003","unstructured":"Smith\u00a0KD, Wrenshall\u00a0LE, Nicosia\u00a0RF et\u00a0al (2003) Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J\u00a0Am Soc Nephrol 14(4):1037\u20131045","journal-title":"J Am Soc Nephrol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01204-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:06:46Z","timestamp":1688548006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01204-6"}},"subtitle":["Nichtentz\u00fcndliche Ver\u00e4nderungen","Non-inflammatory lesions"],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01204-6","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"17 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Gaspert<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0Gaspert gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte Pathologin, Ober\u00e4rztin, Institut f\u00fcr Pathologie und Molekularpathologie, Universit\u00e4tsspital Z\u00fcrich, Z\u00fcrich, | Mitgliedschaften: Renal Pathology Society, European Society of Pathology, Swiss Society of Pathology. <b>M.\u00a0B\u00fcttner-Herold<\/b>: A.\u00a0Finanzielle Interessen: 2022 Vortragshonorar: Pfizer, Onlineworkshop myokardiale Amyloidose, Thema \u201eWelche Informationen liefert der Pathologe?\u201c; 2021 Sanofi Deutschland GmbH, K\u00f6lner TMA Symposium 2021\u00a0\u2013 digital, Thema \u201eNephropathologische Differenzierung der TMA\u201c; 2016\u20132021, Volhard-Fahr-Kurs Mannheim, Thema \u201ePostinfekti\u00f6se GN\u201c; 2018, Berliner Gesell. f\u00fcr\u00a0Pathologie, Thema \u201eRenale Ver\u00e4nderungen bei Systemerkrankungen\u201c.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Pathologin\/Universit\u00e4tsklinikum Erlangen\/FAU Erlangen-N\u00fcrnberg | Mitgliedschaften: ESP, DGfN, IAP, BDP. <b>K.\u00a0Amann<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Novartis, Otsuka, Vifor, STADA Pharma.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00e4. an einer im Medizinbereich aktiven Firma: Roche, Pfizer.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leiterin Nephropathologie, UK Erlangen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}